LabCorp Prices $1B of Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America after the close of the market Monday priced $1 billion of senior notes in two tranches.

The clinical lab giant is offering $500 million of 2.2 percent senior notes due 2017 and $500 million of 3.75 percent senior notes due 2022. The notes bear interest from Aug. 23, 2012, payable in semi-annual installments on Aug. 23 and Feb. 23, beginning Feb. 23, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.